| 0.56 | 1.43% |
| SLXP NASDAQSalix Pharmaceuticals Ltd. | |
Market Cap 2.293B Book Value 6.472 EBITDA -12.0M PEG Ratio 29.94 EPS -1.178 P/B Ratio 6.04 Short Ratio 6.50 Index Membership S&P Sector Healthcare Full Time Employees 395 Profile Get Profile for: Drug Related Products Open 39.06 High 39.75 Low 38.98 Volume 199.4 K Target Price 50.60 Current EPS -1.178 This Year EPS 0.03 Next Year EPS 1.55 This Year PE 1303.33 Next Year PE 25.23 | Symbol | SLXP | | Name | Salix Pharmaceuticals Ltd. | | Type | Stock | | Country | United States | | Exchange | NASDAQ |
| | Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. |
Company Summary more  Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, Salix has products under development for the treatment of hepatic encephalopathy and irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars?Sinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina. Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Top Stories| | 2010-08-31 |  | |
| | |
Earnings Postmortem for NBTY; NTY, PRGO, SLXP, HLF
Learning Markets - Aug 31, 2010
NBTY, Inc. (NTY) [Chart - Analysis - News] released its most recent earnings statement about a month ago on Wednesday, July 28th. NBTY, Inc. beat expectations with a profit of $1.03 per share---21 ...
2010-08-31 |  | |
| | | 2010-08-30 |  | |
| | | 2010-08-30 |  | |
|
| | A rally among airlines and a surprise jump in factory orders pushed US stocks higher in choppy trading on Tuesday. 2010-09-02 |  | |
|
Community Discussions | | | (0.15) | 1.56% |
| CSKI NASDAQChina Sky One Medical Inc. | |
Market Cap 159.3M Book Value 8.768 EBITDA 52.4M EPS 2.252 P/E 4.28 P/B Ratio 1.10 Short Ratio 10.80 Sector Healthcare Full Time Employees 305 Profile Get Profile for: Drug Related Products Open 9.50 High 9.61 Low 9.48 Volume 44.5 K Target Price 23.75 Current EPS 2.252 This Year EPS 2.33 Next Year EPS 2.70 Current PE 4.28 This Year PE 4.14 Next Year PE 3.57 | Symbol | CSKI | | Name | China Sky One Medical Inc. | | Type | Stock | | Country | United States | | Exchange | NASDAQ |
| | China Sky One Medical Inc., through its subsidiaries, develops, manufactures, markets, and sells over-the-counter branded nutritional supplements, and over-the-counter plant and herb-based pharmaceutical and medicinal products primarily in the People?s Republic of China. |
Company Summary more  China Sky One Medical Inc., through its subsidiaries, develops, manufactures, markets, and sells over-the-counter branded nutritional supplements, and over-the-counter plant and herb-based pharmaceutical and medicinal products primarily in the People?s Republic of China. Its products include sumei slim patch to foster weight loss and prevent weight gain; pain relief patch used for various ailments, including fever, headache, heart dysentery, diarrhea, and stiffness and pain caused by hypertension; and anti-hypertension patch that enhances blood circulation and reduces blood pressure. The company also offers hemorrhoids ointment for sterilizing and relieving hemorrhoid symptoms, including itc... China Sky One Medical Inc., through its subsidiaries, develops, manufactures, markets, and sells over-the-counter branded nutritional supplements, and over-the-counter plant and herb-based pharmaceutical and medicinal products primarily in the People?s Republic of China. Its products include sumei slim patch to foster weight loss and prevent weight gain; pain relief patch used for various ailments, including fever, headache, heart dysentery, diarrhea, and stiffness and pain caused by hypertension; and anti-hypertension patch that enhances blood circulation and reduces blood pressure. The company also offers hemorrhoids ointment for sterilizing and relieving hemorrhoid symptoms, including itching, distending pain, burning, and bleeding; compound camphor cream for the treatment of various pathogens on the skin surface and subcutaneously, such as mycete, trichopytic, staphylococcal bacteria aureus, bacillus coli, and candida albicans; stomatitis spray for the treatment of dental ulcers, pharyngitis, and faucitis; cardiac arrest early examination kit used for early stage diagnosis of myocardial infarction; and urinate micro albumin examination testing kit used for early stage diagnosis of primary kidney disease, hypertension, and diabetes. In addition, it provides naftopidil dispersible tablet to treat benign enlargement of the prostate among males in their middle age; and naphazoline hydrochloride eye drop used for the temporary relief of eye redness associated with minor irritations, as well as various suppositories, nasal drops, capsules, granules, injections, and wash fluids. The company sells its products through pharmaceutical chains. China Sky One Medical Inc. is based in Harbin, the People?s Republic of China. China Sky One Medical Inc., through its subsidiaries, develops, manufactures, markets, and sells over-the-counter branded nutritional supplements, and over-the-counter plant and herb-based pharmaceutical and medicinal products primarily in the People?s Republic of China. Its products include sumei slim patch to foster weight loss and prevent weight gain; pain relief patch used for various ailments, including fever, headache, heart dysentery, diarrhea, and stiffness and pain caused by hypertension; and anti-hypertension patch that enhances blood circulation and reduces blood pressure. The company also offers hemorrhoids ointment for sterilizing and relieving hemorrhoid symptoms, including itc... Top Stories| |
Top 10 Most Efficient US-Listed Chinese Stocks: CEO, LPH, RINO, CBEH, SINA, CSKI, ZSTN, CHIO, CYOU, CHL (Aug 30, 2010)
China Analyst - Aug 30, 2010
Below are the top 10 most efficient US-listed Chinese stocks, based on earnings per employee for the last 12 months. CNOOC Limited (ADR) (NYSE:CEO) is the 1st most efficient company in this ...
2010-08-30 |  | |
| | | 2010-08-20 |  | |
| | | 2010-08-12 |  | |
| | |
Top 10 Most Efficient US-Listed Chinese Stocks: CEO, LPH, CBEH, RINO, CSKI, ZSTN, CHIO, CYOU, CHL, CCM (Aug 12, 2010)
China Analyst - Aug 12, 2010
Below are the top 10 most efficient US-listed Chinese stocks, based on earnings per employee for the last 12 months. CNOOC Limited (ADR) (NYSE:CEO) is the 1st most efficient company in this ...
2010-08-12 |  | |
|
Community Discussions |